Dialysis Clearance Prediction

Dialysis clearance prediction quantifies pharmaceutical and metabolite removal rates during renal replacement therapy important for patients requiring dialysis support during acute kidney injury or end-stage renal disease. Molecular weight, protein binding, and water solubility determine dialysability with small hydrophilic substances readily removed. Haemodialysis employing synthetic membranes removes solutes via diffusion; conversely, haemofiltration employs convection-based mechanisms. Peritoneal dialysis utilises peritoneal membrane surfaces producing lower clearance rates.

Clinical pharmacokinetics in dialysed patients require dose adjustment accounting for altered drug elimination. Therapeutic drug monitoring guides individualised dosing preventing subtherapeutic or toxic accumulation. Protein-bound pharmaceuticals exhibit reduced dialysability necessitating careful dosing assessment. Charcoal haemoperfusion and other extracorporeal techniques provide enhanced removal for some substances. Regulatory labelling incorporates dialysis information guiding prescriber decision-making. Emerging dialysate additives and membrane technologies continue improving solute removal capabilities.